Therefore, we used the insurance claims data of Taiwan to conduct this study to evaluate risks of anxiety and/or depression between DM patients with and without GLP1-RA, with sufficient large population-based cohorts and follow-up time. The gene discussed is GLP1R; the disease is depressive disorder.